Active Ingredient History

  • Now
Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer. It targets TRAIL-R1, also known as DR4, which is expressed on the surface of many tumor cell types.   Wikipedia

More Chemistry
hgs-etr1 | mapatumumab | trail-r1 mab | trm-1 | trm-1 hgs-etr1


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue